ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

(2020) G. Curigliano et al.   ANNALS OF ONCOLOGY

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

(2020) C.E. Coles et al.   CLINICAL ONCOLOGY

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'

(2020) Ning Tang   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Essential care of critical illness must not be forgotten in the COVID-19 pandemic

(2020) Tim Baker et al.   LANCET

Cancer guidelines during the COVID-19 pandemic

(2020) Talha Khan Burki   LANCET ONCOLOGY

Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic

(2020) Timothy P. Hanna et al.   Nature Reviews Clinical Oncology

Fair Allocation of Scarce Medical Resources in the Time of Covid-19

(2020) Ezekiel J. Emanuel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic

(2020) Paolo Tarantino et al.   EUROPEAN JOURNAL OF CANCER

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2019) F Cardoso et al.   ANNALS OF ONCOLOGY

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

(2019) Helena M Earl et al.   LANCET

The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment

(2018) Pricivel M. Carrera et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Determinants of Last-line Treatment in Metastatic Breast Cancer

(2018) Marika Cinausero et al.   Clinical Breast Cancer

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial

(2018) Irene L. Wapnir et al.   JOURNAL OF CLINICAL ONCOLOGY

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

(2018) Nancy Fullman et al.   LANCET

Intensive follow-up for women with breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework

(2017) Alessandra Lafranconi et al.   Health and Quality of Life Outcomes

Breast cancer

(2017) Nadia Harbeck et al.   LANCET

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

(2015) Ian H Kunkler et al.   LANCET ONCOLOGY

Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women

(2012) E. M. Kesson et al.   BMJ-British Medical Journal

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer

(2009) Stewart J. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY